title: Reply to letter: "propranolol: a novel antihemangioma agent with multiple potential mechanisms of action".
authors.affiliation: Division of Hand Surgery, Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN harveychim@yahoo.com.
authors.forename: Harvey
authors.initials: H
authors.lastname: Chim
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D042783:Endothelial Cells / Q000187:drug effects*; D006391:Hemangioma / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D014665:Vasodilator Agents / Q000494:pharmacology*
chemical_list: D000319:Adrenergic beta-Antagonists; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D042461:Vascular Endothelial Growth Factor A; D014665:Vasodilator Agents; D011433:Propranolol